Marking the latest move to pledge to spend billions of dollars into the USA, French pharm major Sanofi (Euronext: SAN) ...

Danish dermatology specialist LEO Pharma today released financial results for the first-quarter of 2025, noting its continued ...

Japanese pharma major Takeda (TYO: 4502) announced that the US Food and Drug Administration (FDA) has accepted for priority ...

The US Food and Drug Administration approved Welireg (belzutifan), from US pharma giant Merck & Co (NYSE: MRK), for adult and ...

A clinical-stage biotech company developing targeted therapeutics for rare neurodevelopmental disorders. The company’s lead ...

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) has obtained regulatory approval from the domestic regulator for ...

US analytics specialist Phesi has called for a major rethink in how oncology trials are planned and run, saying clinical ...

US pharma giant Pfizer will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 ...

US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the ...

Chicago-based pharma major AbbVie and privately-held San Diego biotech ADARx Pharmaceuticals have announced a collaboration ...

In a further bid to expand its already lucrative portfolio of metabolic and obesity medicines, Denmark’s Novo Nordisk (NOV: N ...

UK-based Kaerus Bioscience, a biopharma created by European investment firm Medicxi for the development of therapeutics for ...